Liver Disease Management Market Share Analysis, Key Companies, and Forecast To 2030

1
Liver Disease Management Market Size Worth USD
36.01 Billion in 2030
www.emergenresearch.com
Liver Disease Management Market Size USD 22.05
Billion in 2021, Market Growth at a CAGR of
5.6, Market Trends Rising number of novel
diagnostic procedures for liver disease management
. 2
2
Our Model
Market Analysis
Financial Analysis
Distribution Channel Analysis
Brand Analysis
Custom Market Intelligence
Competitor Analysis
Product Analysis
Custom Research
www.emergenresearch.com
Demand Analysis
Risk Analysis
3
Business Plan Parameters
End Use Analysis
Demand Availability Analytics
Market Entry Strategy
Restructuring Revival
New Product Strategy
Product Planning / Strategy
SWOT Analysis
Marketing / Distribution Channel Feasibility
www.emergenresearch.com
Customer Identification Survey
Competitive Landscape / MA Feasibility
www.emergenresearch.com
4
Industries We Cater to
www.emergenresearch.com
5
5
Market Summary
The global Liver Disease Management Market size
reached USD 22.05 Billion in 2021 and is expected
to register a revenue CAGR of 5.6 during the
forecast period, according to latest analysis by
Emergen Research. Rising demand for liver disease
management in various imaging applications for
industrial and manufacturing purposes in addition
to increasing alcohol consumption are some of the
factors driving market revenue growth. Companies
are launching pipeline drugs, and ongoing
clinical trials by several industries are also
driving the market revenue growth of liver
disease management. Rising number of Chronic
Liver Diseases (CLD) and cirrhosis caused by
Non-Alcoholic Fatty Liver Disease (NAFLD),
Hepatitis B Virus (HBV), Hepatitis C Virus (HCV),
and Alcohol Liver Disease (ALD) is rising demand
for liver disease management, as early diagnosis
of CLD and cirrhosis is critical for effective
intervention and improving prognosis. Hepatitis B
is the most prevalent liver problem in the United
States. According to World Health Organization
(WHO), around 85.0 of sepsis cases and
sepsis-related passings overall happened in
low-and center pay countries. Read More
https//www.emergenresearch.com/industry-report/li
ver-disease-management-market
www.emergenresearch.com
6
Market Summary
Some Key Findings From the Report Imaging segment
accounted for a moderate revenue share in 2021.
Tobacco consumption and excessive alcohol intake
contribute to an unhealthy lifestyle, which is
the primary reason for various liver illnesses
such as hepatitis A, hepatitis B, hepatitis C,
jaundice, liver cancer, and cirrhosis. Some
imaging techniques for viewing lesions in a
damaged liver include liver ultrasonography,
Computed Tomography (CT) scans, and Magnetic
Resonance Imaging (MRI). Recently developed
high-level ultrasonography and magnetic resonance
imaging techniques provide consolidated physical
and quantitative practical data on diffuse and
central liver infections. Ultrasound elastography
is important in organizing liver fibrosis and is
becoming more important in assessing entry
hypertension. Anti-viral drugs segment accounted
for a significant revenue share in 2021. Rising
demand for liver disease management owing to the
ability to treat chronic liver problems such as
Non-Alcoholic Fatty Liver Disease (NAFLD) and
hemochromatosis is one of the key factors driving
revenue growth of the segment. Tenofovir
disoproxil, Tenofovir alafenamide, Entecavir,
Telbivudine, Adefovir Dipivoxil, and Lamivudine
are some of the U.S.-approved hepatitis B drugs
are increasing liver disease management market.
Chronic liver illnesses can prompt hepatic
fibrosis, cirrhosis, end-stage liver infection,
entry hypertension, and Hepatocellular Carcinoma
(HCC), and comprise a significant reason for
dreariness, mortality, and medical services
costs. Request Free Sample _at_ https//www.emergenr
esearch.com/request-sample/1367
www.emergenresearch.com
7
Market Summary
Market Segmentation Diagnosis Outlook (Revenue,
USD Million 2019-2030) Endoscopy Imaging Biopsy O
thers Treatment Outlook (Revenue, USD Million
2019-2030) Antiviral drugs Targeted
therapy Chemotherapy End-Use Outlook (Revenue,
USD Million 2019-2030) Clinics Hospitals Diagnost
ic laboratories Request customization _at_
https//www.emergenresearch.com/request-for-custom
ization/1367
8
Parameter Details
Market Size Estimation Period 2020-2028
Base Year Considered 2020
Historical Data 2017-2019
Forecast Period 2021-2028
Quantitative Units Revenue in USD million CAGR from 2020 to 2028
Segments Covered Types, Application, End-Users, Regions more.
Countries Included The U.S., Germany, U.K., Italy, China, India, Japan, Brazil
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Regions Scope North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Customization Scope 10 hours of free customization expert consultation
Pricing and Purchase Options Explore Different Purchase Options Request for Discount to Avail New Year Discount
MARKET SEGMENTATION
www.emergenresearch.com
9
Regional Share Dynamics
www.emergenresearch.com
10
LATEST PUBLICATIONS
Electric Vehicles Market https//www.emergenresear
ch.com/industry-report/electric-vehicles-market F
ire Protection System Market https//www.emergenre
search.com/industry-report/fire-protection-system-
market Sexual Wellness Market https//www.emergen
research.com/industry-report/sexual-wellness-marke
t Solid State Battery Market https//www.emergenr
esearch.com/industry-report/solid-state-battery-ma
rket Lung Cancer Screening Market https//www.eme
rgenresearch.com/industry-report/lung-cancer-scree
ning-market Pushbutton Industrial Wireless
Remote Control Market https//www.emergenresearch.
com/industry-report/pushbutton-industrial-wireless
-remote-control-market Regenerative Medicine
Market https//www.emergenresearch.com/industry-re
port/regenerative-medicine-market Non-Invasive
Prenatal Testing Market https//www.emergenresearc
h.com/industry-report/non-invasive-prenatal-testin
g-market
www.emergenresearch.com
11
At Emergen Research, we believe in advancing with
technology. We are a growing market research and
strategy consulting company with an exhaustive
knowledge base of cutting-edge and potentially
market-disrupting technologies that are predicted
to become more prevalent in the coming
decade. Our expertise umbrellas the
technological environment of all major
industries, and our services help you map your
actions to ensure optimal yield. Our analysts
utilize their market proficiency to offer
actionable insights that help our clients
implement profitable strategies and optimize
their return on investment. Our services are
wide-ranging, right from technological
environment analysis to technological profiling
that highlights the existing opportunities in the
market you can capitalize on to stay ahead of
your competitors.
About Us
www.emergenresearch.com
12
Lets Talk Contact Information
Reach out to us and our Research Executives will
ensure you get the report that meets all your
requirements and address all your concerns.
14671 110 Avenue, Surrey, British Columbia, V3R2A9
www.emergenresearch.com
www.emergenresearch.com
sales_at_emergenresearch.com
1 [phone]